Bloomberg Intelligence cover image

BI Weekend: Delta, Constellation Brands Earnings

Bloomberg Intelligence

00:00

Recent Developments in Drug Coverage Policy

This chapter examines the Trump administration's rejection of a proposal to fund obesity drugs for Medicare patients, highlighting its impact on drug manufacturers. It also discusses the necessity for these companies to pursue legislative backing for future initiatives and mentions a possible scaled-back coverage expansion in Republican legislative plans.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app